logo-loader
viewEmpyrean Energy PLC

Empyrean Energy hits main target in Dempsey well, more ‘significant’ gas shows

"After slow and steady drilling through some very hard rocks over the last few days, we are very encouraged to see the best looking gas shows from another sand," Tom Kelly said.

onshore drilling operation
Drilling continues down to the last target

Empyrean Energy Plc (LON:EME) has given further details from the Dempsey 1-15 well, in the Sacremento basin in California, with additional new reports of significant gas shows.

The company’s partner Sacgasco reported that the well has now drilled through a hard siltstone-shale section into the primary gas bearing sand, with drilling presently advancing below 2,760 metres to evaluate the remaining conventional sandstone remaining target (in the next 440 metres).

"After slow and steady drilling through some very hard rocks over the last few days, we are very encouraged to see the best looking gas shows from another sand in what we now believe to be part of the primary target zone in this well,” said chief executive Tom Kelly.

READ: Empyrean Energy reports multiple ‘significant gas shows’ in Dempsey well

“We have not drilled out of this latest gas bearing sand yet, so it will be interesting to see how thick this zone is.

“We look forward to keeping investors appraised as we progress."

Quick facts: Empyrean Energy PLC

Price: 10.01 GBX

AIM:EME
Market: AIM
Market Cap: £44.34 m
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

FOR OUR FULL DISCLAIMER CLICK HERE

Watch

Full interview: Collagen Solutions released financial number showing more...

Collagen Solutions (LON: COS) CEO Jamal Rushdy joined Steve Darling from Proactive to discuss the company releasing their financial numbers that show impressive double-digit sales growth.  Rushdy talks about the numbers and also their tissue division that continues to be a revenue driver.

10 hours, 8 minutes ago

2 min read